Dynacare Laboratories

Size: px

Start display at page:

Download "Dynacare Laboratories"

Elwin Hampton
5 years ago
Views:

1 Dynacare Laboratories Affiliated with Froedtert & the Medical College of Wisconsin January CPT Code Updates Dear Client: The American Medical Association (AMA) publishes the Current Procedural Terminology (CPT) Coding Manual on an annual basis. For 2015, the AMA made several changes to the Pathology and Laboratory code section of the CPT manual, including 107 new codes added, 47 deleted codes, and 32 revised codes. We have highlighted some important changes below. Toxicology Changes: The AMA added a new section entitled Drug Assay that contains 63 new CPT codes ( ). The codes in the current 2014 Drug Testing section ( ) have been deleted. The 2015 revised codes allow for additional specificity in differentiating the types of specimen being tested. The drug procedures are now divided into the following subsections: Drug Assay Therapeutic Drug Assays Chemistry Under Drug Assay, presumptive procedures are used to identify possible use or non-use of a drug or drug class and may be followed by a definitive test to specifically identify drugs or metabolites. Definitive drug testing may be quantitative or qualitative and does not require prior presumptive testing. Therapeutic Drug Assays are performed to monitor clinical response to a known, prescribed medication. Microbiology Changes: Current CPT code for Human papillomavirus (HPV) has been changed to This code covers testing for HPV High Risk genotypes. Pathology Changes: In the Immunohistochemistry (IHC) and In-situ Hybridization (ISH) code descriptors, the unit of service (UOS) has been changed to per specimen rather than per block for each primary code. Each primary code will also read initial single antibody procedure for IHC and initial single probe stain procedure for ISH. Dynacare Laboratories (12/2014) Page 1

2 Additional 2015 changes include the following additions: New IHC add-on code for each additional antibody stain procedure New ISH add-on code for each additional single-probe procedure New IHC and ISH codes for reporting of multiplex probe stain procedures This summary of CPT code changes provides general guidelines based on the AMA s 2015 CPT Code Manual. Always confirm with the applicable payer to insure appropriate CPT code(s) are used in each case, as the billing party is responsible for its CPT coding. We hope you find this information beneficial to your office staff. Please contact our Client Services department should you have questions. Thank you for selecting Dynacare Laboratories as your laboratory services provider. Sincerely, Dynacare Laboratories Dynacare Laboratories (12/2014) Page 2

3 Attachment I 2015 CPTs in BOLD The CPT Codes listed are in accordance with the current edition of Current Procedural Terminology, a publication of the American Medical Association. CPT codes are provided for the convenience of our clients; however, correct coding often varies from one carrier to another. Consequently, the codes presented here are intended as general guidelines and should not be used without confirming with the applicable payor that their use is appropriate in each case. Molecular Pathology Changes Test number Prostate Cancer Gene 3 (PCA3) Immunohistochemistry (IHC) changes Initial single IHC antibody stain procedure, per specimen Each additional IHC antibody stain on a single specimen Each IHC multiplex antibody stain procedure (ie, multiplex antibody stain 88342, procedure) * Morphometric analysis, tumor immunohistochemistry, quantitative or semiquantitative, each single antibody stain, manual, per specimen Morphometric analysis, tumor immunohistochemistry, quantitative or semiquantitative, each single antibody stain, computer-assisted technology, per specimen *The number of units billed is dependent on the specific multiplex test that is performed. In Situ Hybridization (ISH) changes In situ hybridization, initial single probe, per specimen Each additional single probe stain procedure Each multiplex probe stain procedure, per specimen (ie, multiplex probe stain procedure) * Morphometric analysis, in situ hybridization, quantitative or semiquantitative, initial single probe stain procedure, manual, per specimen Each additional single probe stain procedure, per specimen Each separately identifiable probe applied to the same specimen (ie, multiplex probe stain procedure) * *The number of units billed is dependent on the specific multiplex test that is performed. Dynacare Laboratories (12/2014) Page 3

4 Test number Microbiology Human Papillomavirus (HPV) high-risk with 16/18 genotype Toxicology Test number Acetaminophen, Quantitative Quinidine Salicylate Valproic Acid, Free Amphetamines, Urine Barbiturates, Urine Barbiturate Rapid Screen Benzodiazepines, Urine Benzodiazepine Rapid Screen Cannabinoids, Urine Cocaine/Benzoylecgonine, Urine Ethanol, Urine Ethanol, Serum Methadone, Urine Methaqualone, Urine Opiates, Urine Oxycodone/Oxymorphone, Urine PCP, Urine Propoxyphene, Urine Tricyclic Rapid Screen, Serum Methanol Quantitative, Serum Acetone/Isopropanol, Quantitative, Serum Volatile Screen, Serum Ethylene Glycol, Quantitative, Serum Nicotine and metabolite, Quantitative, Serum Tacrolimus, FK Cyclosporin, Parent Compound Sirolimus (Rapamycin) Everolimus Fentanyl, Quantitative, Urine Oxycodone, Quantitative, Urine Hydrocodone, Quantitative, Urine Methadone, Quantitative, Urine Tramadol, Quantitative, Urine Dynacare Laboratories (12/2014) Page 4

5 Opiates, Quantitative, Urine , 80365, 80361, 80358, Alprazolam (Xanax) Amiodarone Amitriptyline/Nortriptyline Amphetamine Confirmation Urine Barbiturate Confirmation Urine Benzodiazepine Confirmation Urine Buprenorphine Confirmation Urine Buprenorphine Urine Busulfan Cannabinoid Confirmation Urine Carbamazepine Epoxide Chlorpromazine Clomipramine Clonazepam Cocaine Benzoylecgonine Quant Urine Cocaine Meconium Cocaine Metabolite Confirmation Desipramine Dexamethasone Level Diazepam ((Valium) Diuretic Screen Urine Doxepin (Sinequan) Drug Investigation Urine Ethyl Glucuronide Urine Felbamate Fentanyl Confirmation Urine Fentanyl Screen and Confirmation Urine Flecainide Fluoxetine Gold Hydrocodone (Vicodin) Imipramine/Desipramine Lorazepam MDMA (Ecstasy) Qualitative Urine MDMA + Metabolites Confirmation Urine Mephobarbital Mephobarbital (Mebaral) 80184, 80184, Methadone Methadone Confirmation Urine Dynacare Laboratories (12/2014) Page 5

6 Methsuximide Morphine Nicotine Metabolite Urine Nortriptyline Olanzapine (Zyprexa) Opiate Confirmation Urine Opiate Meconium Oxazepam Oxycodone (Percodan) Oxycodone Confirmation Urine Paraldehyde and Acetaldehyde Pentobarbital Propoxyphene Confirmation Urine Risperidone (Risperal) Sulfonylurea Screen THC Meconium Thioridazine (Mellaril) and Mesoridazine Trazodone Trilafon Warfarin Dynacare Laboratories (12/2014) Page 6

MEMORANDUM. Carol Ghere, MT (ASCP) SI, Compliance Officer CPT4 Code Changes from American Medical Association (AMA)

MEMORANDUM. Carol Ghere, MT (ASCP) SI, Compliance Officer CPT4 Code Changes from American Medical Association (AMA) MEMORANDUM TO: FROM: RML Clients Carol Ghere, MT (ASCP) SI, Compliance Officer DATE: January 2, 2015 SUBJECT: 2015 CPT4 Code Changes from American Medical Association (AMA) 2015 CPT4 Code Changes from